• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of written Chemistry, Manufacturing, and Controls (CMC) reviews for New Drug Application supplements (sNDAs) completed by ONDQA during the month (1)

Dictionary: Supplements to NDAs are applications to make changes to an approved marketing application. One of the types of changes made to approved NDAs are how or where the drug is manufactured and/or controlled. This measure includes all review associated the review of chemistry, manufacturing, and controls information submitted in NDA supplements.


This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetNumber
Oct 2009N/A161
Nov 2009N/A170
Dec 2009N/A169
Jan 2010N/A153
Feb 2010N/A133
Mar 2010N/A198
Apr 2010N/A189
May 2010N/A134
Jun 2010N/A149
Jul 2010N/A161
Aug 2010N/A175
Sep 2010N/A214

FY 2010 Total: 2,006

Footnotes

  • (1) Includes all IQA reviews, primary reviews, summary and executive reviews

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.